Literature DB >> 15761032

Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase.

Xinjia Wang1, Donald B DeFranco.   

Abstract

The ubiquitin/proteasome-dependent protein degradation pathway (UPP) is responsible for the accelerated down-regulation of glucocorticoid receptor (GR) levels in cells subjected to chronic glucocorticoid exposure. Whereas hormone-dependent down-regulation of GR operates in most cells, the receptor is not down-regulated after long-term glucocorticoid treatment of either cultured embryonic hippocampal neurons or the HT22 hippocampal cell line. In this report, we show that stable overexpression of the carboxy terminus of heat shock protein 70-interacting protein (CHIP) E3 ligase can restore hormone-dependent down-regulation of GR in HT22 cells. Proteasome inhibitor studies establish that ubiquitylated GR can be efficiently engaged with the proteasome upon CHIP overexpression, unlike the case in parental HT22 cells. In addition to its impact on GR down-regulation, CHIP overexpression alters the coupling between the UPP and GR transactivation. Unlike other steroid receptors whose transactivation properties are typically reduced upon proteasome inhibition, GR transactivation in HT22 cells and other cell lines is enhanced upon proteasome inhibition. However, in HT22 cells overexpressing CHIP, proteasome inhibition leads to a reduction in GR transactivation activity. Thus, the divergent response of a single transactivator (i.e. GR) to the UPP can be dictated by CHIP, an E3 ligase that also functions as a proteasome-targeting factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761032     DOI: 10.1210/me.2004-0383

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  36 in total

1.  Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.

Authors:  Andrew D Wallace; Yan Cao; Sindhu Chandramouleeswaran; John A Cidlowski
Journal:  Steroids       Date:  2010-07-07       Impact factor: 2.668

2.  Turning off estrogen receptor beta-mediated transcription requires estrogen-dependent receptor proteolysis.

Authors:  Yukiyo Tateishi; Raku Sonoo; Yu-ichi Sekiya; Nanae Sunahara; Miwako Kawano; Mitsutoshi Wayama; Ryuichi Hirota; Yoh-ichi Kawabe; Akiko Murayama; Shigeaki Kato; Keiji Kimura; Junn Yanagisawa
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

Review 3.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

Review 4.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

5.  Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function.

Authors:  Tomoshige Kino; Szu-Heng Liou; Evangelia Charmandari; George P Chrousos
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

6.  C-terminus of heat shock cognate 70 interacting protein increases following stroke and impairs survival against acute oxidative stress.

Authors:  Jeannette N Stankowski; Stephanie L H Zeiger; Evan L Cohen; Donald B DeFranco; Jiyang Cai; BethAnn McLaughlin
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

7.  Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation.

Authors:  Heehyoung Lee; Nilanjan Sengupta; Alejandro Villagra; Natalie Rezai-Zadeh; Edward Seto
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.

Authors:  Ekaterina Lesovaya; Alexander Yemelyanov; Kirill Kirsanov; Alexander Popa; Gennady Belitsky; Marianna Yakubovskaya; Leo I Gordon; Steven T Rosen; Irina Budunova
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

Review 9.  Corticosteroids: Mechanisms of Action in Health and Disease.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Rheum Dis Clin North Am       Date:  2016-02       Impact factor: 2.670

10.  CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins.

Authors:  Yoshihiro Morishima; Adrienne M Wang; Zhigang Yu; William B Pratt; Yoichi Osawa; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-09-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.